Patent details
EP3822262
Title:
MUSCARINIC AGONISTS
Basic Information
- Publication number:
- EP3822262
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP202139291
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MUSCARINIC AGONISTS
- French Title of Invention:
- AGONISTES MUSCARINIQUES
- German Title of Invention:
- MUSCARINAGONISTEN
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 10/04/2024
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 18/04/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 27/03/2024
- Unitary Effect Registration Date:
- 18/04/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 03/08/2016
- Grant date:
- 27/03/2024
- EP Publication Date:
- 19/05/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/03/2024
- EP B1 Publication Date:
- 27/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/08/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/05/2024
-
-
- Name:
- Nxera Pharma UK Limited
- Address:
- Granta Park
Great Abington, Cambridge, Cambridgeshire CB21 6DG, United Kingdom (GB)
History of Owners
- From:
- 20/03/2024
- To:
- 17/05/2024
- Name:
- Heptares Therapeutics Limited
- Address:
- Granta Park
Great Abington, Cambridge, Cambridgeshire CB21 6DG, United Kingdom (GB)
Inventor
1
- Name:
- PICKWORTH, Mark
- Address:
- United Kingdom (GB)
2
- Name:
- CONGREVE, Miles Stuart
- Address:
- United Kingdom (GB)
3
- Name:
- TEHAN, Benjamin Gerald
- Address:
- United Kingdom (GB)
4
- Name:
- BROWN, Giles Albert
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 201513742
- Priority Date:
- 03/08/2015
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
-
C07D 401/04;
C07D 401/08;
A61P 25/00;
A61P 25/02;
A61P 25/04;
A61P 25/14;
A61P 25/18;
A61P 25/28;
A61P 25/30;
A61P 29/00;
A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202413
- Publication date:
- 27/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Change of owner's name or address
3
- Issue number:
- 202420
- Publication date:
- 15/05/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |